Marek Kovář
Impact in
- Immunology top 1%
- T-cell and B-cell Immunology
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- Biomaterials top 1%
- Nanoparticle-Based Drug Delivery
Papers in
- Biomaterials 30
- Nanoparticle-Based Drug Delivery 30
- Immunology 29
- Immunotherapy and Immune Responses 17
- T-cell and B-cell Immunology 12
- Immune Cell Function and Interaction 4
- Co-authors
- Onur Boyman (3 shared papers)Jonathan Sprent (3 shared papers)Mark P. Rubinstein (2 shared papers)Charles D. Surh (2 shared papers)Blanka Řı́hová (29 shared papers)Jakub Tomala (22 shared papers)Karel Ulbrich (25 shared papers)Tomáš Etrych (25 shared papers)
- Journals
- Journal of Controlled Release (11 papers)Bioconjugate Chemistry (4 papers)OncoImmunology (4 papers)Biomacromolecules (3 papers)eLife (3 papers)
- Partner nations
- CzechiaUnited StatesFrance
In The Last Decade
Marek Kovář
68 papers receiving 3.1k citations
Peers
Comparison fields: 5 of 81
- Immunology 1.3k
- Biomaterials 738
- Oncology 708
- Microbiology 81
- Pharmaceutical Science 89
Countries citing papers authored by Marek Kovář
This map shows the geographic impact of Marek Kovář's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marek Kovář with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marek Kovář more than expected).
Fields of papers citing papers by Marek Kovář
This network shows the impact of papers produced by Marek Kovář. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marek Kovář. The network helps show where Marek Kovář may publish in the future.
Co-authors
The 25 scholars most cited alongside Marek Kovář, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 70 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 759 | |
| 2 | 2006 | 352 | |
| 3 | 2015 | 189 | |
| 4 | 2001 | 97 | |
| 5 | 2009 | 86 | |
| 6 | 2009 | 80 | |
| 7 | 2024 | 70 | |
| 8 | 2009 | 67 | |
| 9 | 2002 | 65 | |
| 10 | 2018 | 59 | |
| 11 | 2017 | 57 | |
| 12 | 2006 | 50 | |
| 13 | 2019 | 50 | |
| 14 | 2003 | 47 | |
| 15 | 2023 | 47 | |
| 16 | 2016 | 46 | |
| 17 | 2002 | 44 | |
| 18 | 2021 | 44 | |
| 19 | 2004 | 43 | |
| 20 | 2008 | 37 |
About Marek Kovář
Marek Kovář is a scholar working on Biomaterials, Immunology, Oncology, Pharmaceutical Science and Radiology, Nuclear Medicine and Imaging, having authored 70 papers that have together received 3.1k indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (30 papers), Immunotherapy and Immune Responses (17 papers), T-cell and B-cell Immunology (12 papers), Cancer Immunotherapy and Biomarkers (9 papers), Monoclonal and Polyclonal Antibodies Research (4 papers), Immune Cell Function and Interaction (4 papers), Drug Transport and Resistance Mechanisms (4 papers) and Advanced Drug Delivery Systems (3 papers). The work is most often cited by research in Immunology (1.3k citations), Biomaterials (738 citations), Oncology (708 citations), Microbiology (81 citations) and Pharmaceutical Science (89 citations). Marek Kovář has collaborated with scholars based in Czechia, United States and France. Frequent co-authors include Onur Boyman, Jonathan Sprent, Mark P. Rubinstein, Charles D. Surh, Blanka Řı́hová, Jakub Tomala, Karel Ulbrich, Tomáš Etrych, Jiří Strohalm and Jared F. Purton. Their work appears in journals such as Journal of Controlled Release, Bioconjugate Chemistry, OncoImmunology, Biomacromolecules and eLife.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.